ARCHIVES

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

Funding Opportunities

January 17, 2003

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Sledge Elected ASCO President

January 16, 2009